UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

UTAH MEDICAL PRODUCTS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$74.55+0.04 (+0.05%)

Close on Oct 19, 2026

Market cap: $237.37M
P/E (TTM): 22.7
Dividend yield: –

UTAH MEDICAL PRODUCTS INC balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	86	83	93	75	61	52	43	51	40	26	23	19	14	8.87	6.53	3.82	0.41	0.10
Cash & Short-Term Investments	86	83	93	75	61	52	43	51	40	26	23	19	14	8.87	6.53	3.82	0.41	0.10
Receivables	3.52	4.09	3.39	5.54	5.13	4.10	4.74	3.96	3.62	3.21	4.56	4.70	4.34	4.34	4.73	3.16	–	–
Inventory	7.94	8.81	9.58	8.81	6.60	6.22	6.91	6.91	5.24	4.54	4.20	4.87	4.70	4.35	5.01	3.10	–	–
Prepaid Expenses & Other	–	–	–	–	–	–	–	–	–	–	0.42	0.47	0.47	0.48	0.35	0.16	–	–
Other Current Assets	0.53	0.45	0.43	0.52	0.46	0.35	0.44	0.42	0.37	0.36	0.42	0.77	0.80	0.93	0.68	0.35	–	–
Total Current Assets	98	96	106	90	73	62	55	61	49	34	33	30	24	19	17	25	–	–
Property, Plant & Equipment	9.91	9.76	11	10	11	11	11	10	12	9.97	7.37	8.24	8.33	8.43	8.81	8.75	–	–
Gross Property, Plant & Equipment	35	34	34	33	33	34	33	32	32	30	27	28	28	27	27	–	–	–
Accumulated Depreciation	-25	-24	-24	-23	-23	-23	-22	-21	-21	-20	-20	-19	-19	19	18	–	–	–
Land	1.70	1.60	1.64	1.59	1.69	1.73	1.67	1.65	1.34	1.29	1.30	1.34	1.40	1.38	1.37	–	–	–
Buildings & Improvements	14	14	14	14	14	15	14	14	15	11	10	11	11	10	10	–	–	–
Machinery & Equipment	19	19	17	17	17	17	16	16	16	16	16	15	16	15	15	–	–	–
Construction in Progress	0.11	0.02	1.41	0.91	0.90	0.53	0.37	0.14	0.01	2.06	0.03	0.13	0.03	0.05	0.18	–	–	–
Operating Lease Right-of-Use Assets	0.29	0.34	0.34	0.40	0.45	0.38	0.41	0	–	–	–	–	–	–	–	–	–	–
Goodwill	14	14	14	13	14	14	14	14	14	13	15	15	16	15	15	7.19	–	–
Intangible Assets	0.84	2.87	4.95	10	18	24	30	15	18	18	24	28	32	34	35	0.16	–	–
Total Assets	123	123	135	124	116	112	110	100	93	76	79	81	81	77	76	41	–	–
Accounts Payable	0.91	0.70	0.77	1.22	0.76	0.79	1.10	0.98	0.93	0.91	0.65	0.93	0.77	1.00	0.93	0.40	–	–
Accrued Expenses	1.69	3.06	3.94	4.74	2.98	3.00	2.35	4.29	4.35	2.12	3.42	4.15	2.79	2.82	3.28	1.29	–	–
Current Portion of Leases	0.06	0.06	0.05	0.05	0.05	0.04	0.04	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	0.33	0.34	0.04	0.00	0.45	0.85	1.26	0.80	1.63	2.45	1.24	1.38	1.07	–	–	–
Total Current Liabilities	2.60	3.76	4.71	5.96	3.75	3.79	3.45	5.26	5.28	3.02	4.07	8.97	7.61	7.82	9.63	1.90	–	–
Long-Term Debt	0.23	0.28	0.30	–	–	–	–	–	–	–	0	0.97	5.07	9.00	16	0.91	–	–
Long-Term Leases	0.23	0.28	0.30	0.34	0.40	0.34	0.38	0	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.29	0.28	0.34	0.40	0.45	0.38	0.41	0	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	0.34	0.47	0.32	0.55	0.58	0.65	0.52	0.54	0.46	0.72	1.01	1.00	0.94	0.88	0.69	–	–	–
Other Long-Term Liabilities	–	0	0.70	1.26	1.68	2.00	2.24	2.44	5.79	–	–	0	0	0.36	0.52	–	–	–
Total Liabilities	3.27	5.11	7.15	9.62	8.50	8.92	8.69	11	15	6.95	9.53	17	20	26	36	3.45	–	–
Total Debt	0.23	0.28	0.30	–	–	–	–	–	–	–	0	0.97	5.07	9.00	16	0.91	–	–
Preferred Stock	–	–	–	–	–	–	0	0	0	–	–	–	–	–	–	–	–	–
Common Stock	0.03	0.03	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	–	–
Additional Paid-In Capital	0	0	0.59	0.25	0.84	0.12	0.02	0.12	0.81	0.38	2.71	2.89	3.28	2.27	0.72	0.11	–	–
Retained Earnings	129	129	138	126	115	111	111	100	86	81	73	65	57	50	43	39	–	–
Shareholders' Equity	119	117	128	114	107	103	101	89	78	69	70	65	61	51	41	38	–	–
Total Equity	119	117	128	114	107	103	101	89	78	69	70	65	61	51	41	38	–	–
Total Liabilities & Equity	123	123	135	124	116	112	110	100	93	76	79	81	81	77	76	41	–	–
Shares Outstanding(shares)	3.19	3.34	3.63	3.63	3.66	3.64	3.72	0.00	0.00	3.71	3.75	3.75	3.74	3.70	3.64	3.62	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 57.9%
Operating margin: 28.4%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 48.62
Debt to equity: 0.00
Debt to assets: 0.2%
Cash to current liabilities: 4228.4%

Valuation

P/E ratio: 22.7
Price to sales: 6.57
Price to book: 1.95
Dividend yield: –